# The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

> **NCT00516971** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 200 (estimated)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Esomeprazole 20mg once daily

## Key facts

- **NCT ID:** NCT00516971
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516971, "The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00516971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*